If Pat Smith an ILADS don't cut the crap, THEY'RE the ones who are going to get nailed for racketeering
Foley Hearts Chuck
Date: Tue, 10 Oct 2006 11:34:55 -0700 (PDT)
From: "Urr Eeka" <urr...@yahoo.com> Add to Address BookAdd to Address
Book Add Mobile Alert
Subject: LDA Press Release...!!...Re: Corruption on both sides of the
Lyme Disease Divide
To: thomas...@usdoj.gov, dh...@courant.com, hor...@courant.com,
NE...@courant.com, bmi...@newstimes.com,
eliot....@oag.state.ny.us, tr...@hotmail.com, rast...@aol.com,
bill...@comcast.net, amcg...@rms-law.com, rjmu...@aol.com, Send an
Instant Message paulcrai...@yahoo.com, Send an Instant Message
sidney_b...@yahoo.com, Vicky...@mslpr.com,
criminal...@usdoj.gov, karla.d...@usdoj.gov,
lyme...@aol.com, christophe...@usdoj.gov, fra...@ucia.gov,
govern...@po.state.ct.us, fit...@gmail.com,
patrick.f...@usdoj.gov, model...@sbcglobal.net
CC: Jgerb...@cdc.gov, con...@po.state.ct.us,
executiv...@nytimes.com, managin...@nytimes.com,
news...@nytimes.com, dv...@cdc.gov, brigidc...@optonline.net,
tr...@hotmail.com, james.p...@yale.edu, ma...@concentric.net,
jhorn...@fff.org, leonar...@po.state.ct.us, FalN...@aol.com,
brans...@comcast.net, vts...@comcast.net, mcne...@aol.com,
o...@po.state.ct.us, da...@davila-dilzer.com,
scott....@po.state.ct.us, attorney...@po.state.ct.us,
patrick....@jud.state.ct.us, thoma...@po.state.ct.us,
cpoi...@courant.com, Loftu...@cs.com
General Broomstick has spoken:
Statement From Pat Smith, President, Lyme Disease Association
Oct 10, 10:33 AM
JACKSON, N.J., Oct. 10 /PRNewswire/ -- The national non-profit Lyme
Disease Association (LDA), representing more Lyme disease patients than
any organization in the United States, objects strenuously and with
great alarm, to the restrictive new Clinical Practice Guidelines
published this October by the Infectious Diseases Society of America
(IDSA). The new guidelines make it far more likely that Lyme disease
will be missed in the early stages, when it is easier to treat. As a
result, the guidelines set the stage for creation of a new generation
of chronic Lyme disease patients, individuals with Lyme disease
diagnosed and treated so late that they may never be cured.
In a nutshell, the reckless new IDSA guidelines forbid doctors from
using clinical discretion in determining whether or not patients have
Lyme disease. Instead, they require that doctors either see a
characteristic rash known to occur in about half the patients, or that
patients register positive on the two tests recommended by the Centers
for Disease Control & Prevention (CDC) -- tests known to miss up to
half the patients. At any stage of disease, as many as half the
patients may remain undiagnosed.
Lyme disease diagnosed late and allowed to disseminate for months or
years without treatment causes severe disease that may never completely
resolve. Late stage patients suffer more sequelae -- continued symptoms
-- after treatment and are far more likely to fail treatment than
patients diagnosed in a timely fashion, with early Lyme disease.
Late-stage patients suffering chronic symptoms are frequently very sick
and in great pain, often as impaired as those with congestive heart
failure and sicker than people with type two diabetes.
Despite the basic math and the documented sequelae of late-diagnosed
and late-treated Lyme disease, the new IDSA Guidelines state (without
offering evidence or any supporting citations) that most Lyme patients
are diagnosed early. This defies the experience of the LDA and of the
patient community. It is also flies in the face of a study, now in
press at the Journal of Evaluation in Clinical Practice, which has
found that when patients fail treatment, the reason is overwhelmingly
because they were diagnosed and treated late.
The IDSA guidelines also deny that chronic persistent infection exists,
arbitrarily dismissing all studies documenting persistent infection
after short-term therapy and ignoring mounting evidence that more
treatment is beneficial in chronic cases.
Finally, the IDSA guidelines fail to even mention another set of
diagnostic and treatment guidelines published by the International Lyme
and Associated Diseases Society (ILADS) listed with the National
Guideline Clearinghouse, which offer an alternative view of Lyme
disease diagnosis and treatment.
LDA understands that the debate over the cause of chronic Lyme disease
continues to be contentious and to divide those treating and studying
the disease. There continue to be two standards of care. But the need
to diagnose Lyme disease early enough to obtain the best treatment
outcome and most favorable prognosis has never been controversial.
Despite this, the IDSA guidelines are so draconian they stand poised to
let many patients slip through the cracks and elude diagnosis until
they are suffering late-stage, difficult-to-treat Lyme disease. *** As
the voice of the Lyme disease patient community, LDA challenges these
guidelines on humanitarian grounds.***
http://www.lymediseaseassociation.org/
Lyme Disease Association
CONTACT: Vicky Jaffe, MS&L, +1-617-937-2578, Vicky...@mslpr.com
Web site: http://www.lymediseaseassociation.org/
======
2:30 PM Eastern:
The deal is you have to talk science, but that does not satisfy Mrs.
Earth's Axis, nor Igenex, since they have a monopoly on Lyme testing by
virtue of their virtue (they're really a good Lyme, especially since
BBI Labs was sold). So, it does not satisfy the owner of Igenex for
the status quo to change, and we *resolve* this issue of the bogus
testing for Lyme (as demonstrated below with the SCIENCE).
If ILADS and Pat Smith don't cut the crap, they're the ones who are
going to get nailed for racketeering.
KMDickson
==========
Tuesday, October 10, 2006 5:39:33 AM
Urr Eeka <urr...@yahoo.com> wrote:
Nick Harris owns Igenex labs, and Pat Smith is in charge of the
Lyme Disease Association based in New Jersey.
=========================
From:
Oracle2 ActionLyme <oracle2a...@yahoo.com>
[Add to Address Book]
To: [snip]
Subject:
SuperBlumenthal and "Target Imbalance"
Date:
Tuesday, October 10, 2006 5:39:33 AM
[View Source]
Note what I told [blankity blank] (below).
The testing is bogus and that is fine with Nick Harris, since his
is the only legitimate lab in the country and he therefore gets all the
business. Yale's RICO plan to get all the national blood See:
http://www.actionlyme.org/LYME_CORRUPTICUT.htm
was foiled, so NIH just gave them a 31.4 million dollar grant to
assimlate batches of patients (they are going to open a clinical center
since they're totally clueless and intellectually uncoordinated). I
wonder who could have approved this grant, since McSweegan is in charge
of approving grants?
In three instances the bad guys revealed that the know all the
testing for Lyme is bogus and that you can't use any Osp primers, or
products for antibody testing, so take note:
1) Target Imbalance by Dave Persing (get the whole text):
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=PureSearch&db=pubmed&details_term=8158048%5BUID%5D
2) Firstly, in 1990, by Andrew Pachner, sampling bugs from brains,
(and note that this was an invitro study, so he never proved
antibiotics cleared the spirochetes in the brain (they don't, which is
what the Pfizer scientists told me, and Pfizer's researchers belonged
to the Jay Sanford ID group, which was not IDSA):
And 3) Fikrig at Yale says the same thing, for a third time:
The only primers you can use are the intragenic spacers RNA and
flagellin DNA and product and NEVER any DNA from any varying Osps.
Now when are you people going to get down and dirty on this? Nick
certainly has the money to hire a law firm. Are you waiting for me to
croak?
Somebody better grow a pair because your non-action is hurting more
Lyme patients every day. The status quo is fine for Nick and he should
not be in charge of ILADS and making all the decisions. Pat Smith
should not be on the board of ILADS if Nick is giving her money.
The whole thing sucks, and I recommend some synthetic steroid use
for all of you, if ya can't find a whole pair of nuts between yuz.
Kathleen
Date:
Sat, 7 Oct 2006 15:03:59 -0700 (PDT)
From:
"Oracle2 ActionLyme" <oracle2a...@yahoo.com> Add to Address
Book Add Mobile Alert
Subject: IDSA 2006 Guidelines' Problems
To: [snip]
The three main things wrong with IDSA guidelines are
1) The Dearborn/Steere antibody testing schema we have now for Lyme
is bogus, which means Klempner's study is bogus. That, we already
demonstrated was invalid as soon as it came out:
http://www.ilads.org/position2.html
The testing for Lyme is bogus, therefore we have no idea what kind
of patients Klempner had, and he refused to answer me when I asked
Klempner what primers he used to sample spinal fluid in those patients.
This CDC testing we have now is only to verify Lyme arthritis,
because Borreliosis is actually a bioweapon, as we learned from
McSweegan's old Bioterror website, and is a "stealth disabler"- which
means low or no antibody response
http://www.actionlyme.org/
verify with the published data on linked from my website.
A) The US Army says ticks could be used as bioweapons to spread
disease,
B) The Department of Energy calls Lyme "the perfect stealth
bacteria" which means it sually does not have the Steere/Dearbor kind
of antibody response;
C) UNSCOM was looking fotr tic nursery equipment in Iraq before
duyba dubya dubya dot dubya's bogus 9/11 war with the bogus Niger
uranium letter and the thermite in the WTC dubya dubya three.
Lyme arthritis, is a genetically-linked outcome. Like, not everyone
has seasonal allergies, and not everyone has a genetic predisposition
to have arthritis.
Klempner also explains it here:
http://www.actionlyme.org/Klempner-0602.wmv
The difference in the blots you see here, are clear:
http://www.actionlyme.org/USDOJ_COMPLAINT_RICO.htm
On the right, the darker bands means higher antibody concentration
(is an inflammatory/genetically linked arthritis or acrodermatitis
response)
2) Any DNA testing for Lyme in a patient has to be the non-changing
kind. No OspA gene or anything like it, but only Borreliae genus and
species specific flagellin, or the same primers that Wormser et al use
to look for Borreliae in ticks or in erythema rashes that they used
previously. (16-23S RNA, RNA spacers)
http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=9986813
Barbour's lonestari flagellin patent:
http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=5,932,220.PN.&OS=PN/5,932,220&RS=PN/5,932,220
Notice that these are non-varying DNA primers, and are the
essentional ones to be used all the time when testing patients via a
DNA method.
Flagellin or the Borreliae specific intragenic spacers.
ONLY.
Right now no one uses these primers. None of these valid genus and
species (some say Phylum and some say Order) primers were used in any
treatment or diagnois protocols, nor are they even available to the
public by any lab.
3) The IDSA treatment on tickbite plan has never ben validated, in
the manner disemination had been checked in the past, where Ray
Dattwyler says he sampled the spinal fluid of people who showed up in
his clinic with EM rashes and found Bb DNA in 2/3 of those people.
http://www.actionlyme.org/Dattwyler_Luft_Bb_DNA_in_CSF.htm
IDSA offers no similar proof that their short treatment protocol
for tick bite is valid. They did not sample the spinal fluid of people
who were treated with one dose of doxy, 3 ot 4 weeks later and, using
the right primers, determine that the brain had no been invaded.
If ya want more references for these, uh coorse, ya got em. Just
let me know.
Kathleen
the 3rd Man
Foley Hearts Chuck wrote:
> Date: Tue, 10 Oct 2006 11:34:55 -0700 (PDT)
> From: "Urr Eeka" <urr...@yahoo.com> Add to Address BookAdd to Address
> Book Add Mobile Alert
>
> Subject: LDA Press Release...!!...Re: Corruption on both sides of the
> Lyme Disease Divide
>
> going to get nailed for racketeering.
>
> KMDickson
LOL.
Nice to see she doesn't play favorites...